MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./360/0.1/21.03.25 Share Price

Warrant

DE000MG29F18

Market Closed - Bid/Ask 17:52:57 15/05/2024 BST After market 20:57:30
0.122 EUR -0.81% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./360/0.1/21.03.25 0.139 +13.93%
Current month-34.22%
1 month-28.90%
Date Price Change
15/05/24 0.122 -0.81%
14/05/24 0.123 -3.15%
13/05/24 0.127 +6.72%
10/05/24 0.119 -32.39%
09/05/24 0.176 -8.33%

Delayed Quote Börse Stuttgart

Last update May 15, 2024 at 05:52 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG29F1
ISINDE000MG29F18
Date issued 12/04/2024
Strike 360 $
Maturity 21/03/2025 (310 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.194
Lowest since issue 0.103
Spread 0.031
Spread %20.00%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
235 USD
Average target price
278.8 USD
Spread / Average Target
+18.65%
Consensus